We read with interest the correspondence by Xiao et al. in The Lancet Gastroenterology & Hepatology discussing the prevention of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with decompensated cirrhosis.1 We have reviewed the available literature (published in PubMed, EMBASE, and Web of Science up to April 13, 2020) for potential mechanisms that would place cirrhotic patients at increased susceptibility to COVID-19 infection.

ACE2: A Linkage for the Interplay Between COVID-19 and Decompensated Cirrhosis

Targher, Giovanni
Writing – Review & Editing
;
2020-01-01

Abstract

We read with interest the correspondence by Xiao et al. in The Lancet Gastroenterology & Hepatology discussing the prevention of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with decompensated cirrhosis.1 We have reviewed the available literature (published in PubMed, EMBASE, and Web of Science up to April 13, 2020) for potential mechanisms that would place cirrhotic patients at increased susceptibility to COVID-19 infection.
2020
COVID-19; cirrhosis; ACE2
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1024170
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact